These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1665830)
41. Regulation of angiotensin II receptors and steroidogenic responsiveness in cultured bovine fasciculata and glomerulosa adrenal cells. Penhoat A; Jaillard C; Crozat A; Saez JM Eur J Biochem; 1988 Feb; 172(1):247-54. PubMed ID: 2831060 [TBL] [Abstract][Full Text] [Related]
42. Effect of an angiotensin II receptor antagonist, CV-11974, and its prodrug, TCV-116, on production of aldosterone. Wada T; Inada Y; Sanada T; Ojima M; Shibouta Y; Noda M; Nishikawa K Eur J Pharmacol; 1994 Feb; 253(1-2):27-34. PubMed ID: 8013547 [TBL] [Abstract][Full Text] [Related]
43. Binding characteristics and vascular effects of various angiotensin II antagonists. Criscione L; Thomann H; Whitebread S; de Gasparo M; Bühlmayer P; Herold P; Ostermayer F; Kamber B J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S56-9. PubMed ID: 1705629 [TBL] [Abstract][Full Text] [Related]
44. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation. Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754 [TBL] [Abstract][Full Text] [Related]
45. Oxytocic effect of trypsin on the isolated rat uterus. Orce G; Castillo G; Esteban S Hypertension; 1994 Jan; 23(1 Suppl):I250-5. PubMed ID: 8282369 [TBL] [Abstract][Full Text] [Related]
46. AT1 angiotensin receptors mobilize intracellular calcium in a subclone of NG108-15 neuroblastoma cells. Ransom JT; Sharif NA; Dunne JF; Momiyama M; Melching G J Neurochem; 1992 May; 58(5):1883-8. PubMed ID: 1560241 [TBL] [Abstract][Full Text] [Related]
47. Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan. Abdelrahman A; Pang CC Can J Physiol Pharmacol; 1992 May; 70(5):716-9. PubMed ID: 1423014 [TBL] [Abstract][Full Text] [Related]
48. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist. Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370 [TBL] [Abstract][Full Text] [Related]
49. Nonpeptide angiotensin II receptor antagonist recognizes inter-species differences in angiotensin AT1 receptors. Kawano K; Fujishima K; Nagura J; Yasuda S; Shinki ; Hachisu M; Konno F Eur J Pharmacol; 1998 Sep; 357(1):33-9. PubMed ID: 9788771 [TBL] [Abstract][Full Text] [Related]
50. The angiotensin hexapeptide 3-8 fragment potently inhibits [125I]angiotensin II binding to non-AT1 or -AT2 recognition sites in bovine adrenal cortex. Jarvis MF; Gessner GW; Ly CQ Eur J Pharmacol; 1992 Aug; 219(2):319-22. PubMed ID: 1425957 [TBL] [Abstract][Full Text] [Related]
51. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist. Bertolino F; Valentin JP; Maffre M; Jover B; Bessac AM; John GW J Pharmacol Exp Ther; 1994 Feb; 268(2):747-52. PubMed ID: 8113986 [TBL] [Abstract][Full Text] [Related]
52. Immunological reactivity of angiotensin II receptor antagonists: possible implications for receptor binding sites. Bensoussan M; Mitchell T; Reilly T; Timmermans PB; Verroust PJ; Ronco PM Eur J Pharmacol; 1993 Oct; 247(2):169-75. PubMed ID: 8282006 [TBL] [Abstract][Full Text] [Related]
53. Characterization and coupling of angiotensin-II receptor subtypes in cultured bovine adrenal fasciculata cells. Ouali R; Poulette S; Penhoat A; Saez JM J Steroid Biochem Mol Biol; 1992 Oct; 43(4):271-80. PubMed ID: 1327066 [TBL] [Abstract][Full Text] [Related]
54. Effects of irbesartan (SR47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action. Christophe B; Libon R; Cazaubon C; Nisato D; Manning A; Chatelain P Eur J Pharmacol; 1995 Aug; 281(2):161-71. PubMed ID: 7589203 [TBL] [Abstract][Full Text] [Related]
55. 4-(Heteroarylthio)-2-biphenylyltetrazoles as nonpeptide angiotensin II antagonists. Norman MH; Smith HD; Andrews CW; Tang FL; Cowan CL; Steffen RP J Med Chem; 1995 Nov; 38(23):4670-8. PubMed ID: 7473594 [TBL] [Abstract][Full Text] [Related]
56. Pharmacological characterization of angiotensin-induced depolarizations of rat superior cervical ganglion in vitro. Hawcock AB; Barnes JC; Michel AD Br J Pharmacol; 1992 Mar; 105(3):686-90. PubMed ID: 1628155 [TBL] [Abstract][Full Text] [Related]
57. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission. Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569 [TBL] [Abstract][Full Text] [Related]
58. Angiotensin II receptors and angiotensin II receptor antagonists. Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104 [No Abstract] [Full Text] [Related]
59. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme. Campbell DJ; Kladis A; Valentijn AJ J Cardiovasc Pharmacol; 1995 Aug; 26(2):233-40. PubMed ID: 7475048 [TBL] [Abstract][Full Text] [Related]
60. Mapping of angiotensin II receptor subtype heterogeneity in rat brain. Song K; Allen AM; Paxinos G; Mendelsohn FA J Comp Neurol; 1992 Feb; 316(4):467-84. PubMed ID: 1577995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]